This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Commercial Biomanufacturing Ireland
See you next year!
Stay tuned for updates on Commercial Biomanufacturing Ireland 2025
Menu
keyboard_arrow_right

Day Two - Wednesday 4th December, 2024 - GMT (Greenwich Mean Time, GMTZ)

keyboard_arrow_leftSearch & Filter
search
Day Two - Wednesday 4th December, 2024 - GMT (Greenwich Mean Time, GMTZ)
search
Showing 1 of 1 Streams
08:55 - 09:05
Chairperson’s Opening Remarks - Challenges & Opportunities in the Biomanufacturing Sector - Emerging Technologies & Models in Commercial Manufacturing
  • Tiffany Rau - Adjunct Professor of Biochemistry & Cell Biology | Owner & Principal Consultant, University College Cork | Rau Consulting USA | Bio Pharma Technical Consulting IRE
09:05 - 09:40
The Role of Contract Development & Manufacturing Organizations (CDMOs) in Commercial Manufacturing in Ireland

Analyse CDMO partnership success factors. Evaluate outsourcing benefits versus in-house capabilities. Ensure scalability, consistency, and data security in CDMO collaborations. Provide access to GMP facilities for smaller companies.

  • Connie Leach - Global Director Quality, Compliance & Regulatory Services, CAI, Ireland
  • Rachel Harte - Associate Director Regulatory Affairs, CAI, Ireland
09:40 - 10:15
Understanding Manufacturing Models & Strategies

Jazz Pharmaceuticals employ a risk based approach to new vendor onboarding – a technical deep dive to evaluate capabilities, identify risks and opportunities and establish mitigation / improvement plans, with a cross functional team across MS&T, QC / Analytical, Facilities and Utilities Eng and Process development.


  • Derek Lonergan - Director, New Product Integration MS&T, Jazz Pharmaceuticals, Ireland
Showing 1 of 1 Streams
10:15 - 11:00
Networking Refreshment Break with Exhibit and Poster Viewing
Showing 1 of 1 Streams
11:00 - 11:35
Manufacturing Digitization: MES in the Cloud

Explore cloud MES benefits and challenges. Evaluate vendor offerings. Consider MES-specific cloud requirements. Anticipate future trends.

  • Brian Reynolds - Digital Manufacturing Lead, Johnson & Johnson, Ireland
11:35 - 12:10
Cell and Gene therapy: Challenges and Opportunities

Enhance Ireland's CGT profile through effective marketing. Leverage Irish location for CGT advantages.

  • Frank Barry - Professor of Cellular Therapy, National University of Ireland Galway and Principle Investigator, Regenerative Medicine Institute (REMEDI), Ireland
Showing 1 of 1 Streams
12:10 - 13:10
Networking Luncheon with Exhibit and Poster Viewing
Showing 1 of 1 Streams
13:10 - 13:20
Chairperson’s Opening Remarks - Workforce Considerations
  • Tiffany Rau - Adjunct Professor of Biochemistry & Cell Biology | Owner & Principal Consultant, University College Cork | Rau Consulting USA | Bio Pharma Technical Consulting IRE
13:20 - 14:30
The Future of the Biomanufacturing Workforce in Ireland

Developing a skilled workforce, expanding talent pools, and leveraging government support for education are crucial to meet biomanufacturing demands.

  • Shada Warreth - Global Partnerships Implementation Senior Manager, TU Dublin, NIBRT, Ireland
  • Brian O'Connor - Vice President, Global Quality, Orchard Therapeutics, Ireland
  • Sidney Reid - Chief Operations Officer, CASTL, Canada
Showing 1 of 1 Streams
14:30 - 15:00
Networking Refreshment Break with Exhibit and Poster Viewing
Showing 1 of 1 Streams
15:00 - 15:40
Galapagos' Innovative Decentralized Manufacturing Model for Cell Therapy
  • Overview of Galapagos and our innovative decentralized T cell therapy manufacturing platform and clinical programs
  • Key elements enabling scalable and consistent decentralized production at global scale
  • Real world experience with a decentralized CAR-T manufacturing platform supporting Phase I/II clinical trials at the point-of-care in EU
  • Ruiz Astigarraga - Head of Manufacturing - Cell Therapy, Galapagos
  • Lee Buckler - Senior VP of Advanced Therapies, BCA Advanced Therapies Network
15:40 - 16:20
Fuelling Funding: Securing the Future Innovation and Development of Advanced Therapies & Biologics in Ireland & Beyond
  • Panellists’ experiences and expertise in the space.
  • Reimbursement & Market access considerations.
  • How can we create links between academia, SMEs and pharma?
  • Current funding landscape: VC, Angel, Grants, etc.
  • Innovative funding mechanisms to balance risk and reward for investors and developers.
  • Recovering from the Covid Bubble bursting
  • Ensuring equitable access to advanced therapies across different economic landscapes.
  • Impact of new EU Pharmaceutical Legislation – Intellectual Property Rights: How will this affect Biopharma?
  • Rory Mullen - Head of BioPharma and Food, IDA Ireland, Ireland
  • Eimear O'Leary - Director of Communications and Advocacy, Irish Pharmaceutical Healthcare Association, Ireland
  • Eric Halioua - President & Chief Executive Officer, PDC*line Pharma
  • Dr Hiro Usuda - Scouting & Transaction Lead, Business Development, Astellas Innovation Management LLC
Showing 1 of 1 Streams
16:20 - 16:25
Close of Conference
Day One - Tuesday 3rd December, 2024
Filter
Streams
Formats
Choose Day